Beneficial Effects of Testosterone Undecanoate on the Lipoprotein Profiles in Healthy Elderly Men. A Placebo Controlled Study.
Open accessAbstract
BACKGROUND AND METHODS: In order to assess the effects of testosterone undecanoate (TU; 120 mg/d orally for 2 months) on serum lipid, lipoprotein, and apolipoprotein levels in healthy elderly men, the placebo (PL) controlled study was performed on 37 elderly men, aged between 53 and 89 years. In all subjects venous blood samples were taken after an overnight (10 hours) fast and sera were stored -70 degrees C until analysis. RESULTS: In PL group, neither hormonal data nor lipid, lipoprotein, and apolipoprotein levels showed significant changes. After TU supplementation, serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and estradiol (E2) levels decreased from 198 +/- 30.7 mg/dl to 174 +/- 41.9 mg/dl (p < 0.05), from 111 +/- 18.14 mg/dl to 87.9 +/- 29.4 mg/dl (p < 0.01), and from 86.2 +/- 16.9 pmol/l to 70.5 +/- 18 pmol/l (p < 0.01), respectively. Statistically significant differences were not observed in the serum triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and apolipoprotein (apo) A-1 and apo B levels after TU treatment. The mean ratios TC/HDL-C and LDL-C/HDL-C as coronary risk factor criteria decreased significantly in the TU but not in the PL group. No obvious side effect was observed in those who took TU except for reported pyrosis in 2 of 17 elderly men. CONCLUSIONS: These data indicate that the increased serum levels of total testosterone (TT) produced by administration of TU, 120 mg/d orally for 2 months lead to suppressed levels of TC and LDL-C and E2 but not significantly changed levels of TC, HDL-C, apo A-1 and apo B. Thus, we conclude that TU may be an effective drug for protecting coronary heart disease in healthy elderly men with lowered TT and FT levels. It may also have beneficial effects for sexual function and behavior.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In most studies testosterone effects modest reductions of total and LDL cholesterol.
“Despite some conflicting data, in most studies testosterone effects modest reductions of total and LDL cholesterol.22-24”
From Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life (2004) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163 · see citing works
Gray, A., Feldman, H. A., McKinlay, J. B., & Longcope, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,104 · see citing works
Loss of Circadian Rhythmicity in Blood Testosterone Levels with Aging in Normal Men*
Bremner, W. J., Vitiello, M. V., & Prinz, P. N. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1278 · Cited by 785 · see citing works
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768 · see citing works
Effects of testosterone supplementation in the aging male.
Tenover, J. S. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 702 · see citing works
Vermeulen, A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-221 · Cited by 393 · see citing works
Hormonal Changes and Sexual Function in Aging Men*
Davidson, J. M., Chen, J. J., CRAPO, L., Gray, G. D., GREENLEAF, W. J., & Catania, J. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-1-71 · Cited by 377 · see citing works
Mårin, P., Odén, B., & Björntorp, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829619 · Cited by 332 · see citing works
Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions
Godsland, I. F., Wynn, V., Crook, D., & Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90552-7 · Cited by 322 · see citing works
Gordon, D. J., Knoke, J. D., Probstfield, J. L., Superko, H. R., & Tyroler, H. A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1217 · Cited by 289 · see citing works
HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons
Corti, M.-C. (1995) · JAMA · doi:10.1001/jama.1995.03530070037026 · Cited by 284 · see citing works
Zilversmit, D. B. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.153 · Cited by 262 · see citing works
Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men
Bagatell, C. J., Heiman, J. R., Matsumoto, A. M., Rivier, J., & Bremner, W. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045977 · Cited by 244 · see citing works
Decreased Bioavailable Testosterone in Aging Normal and Impotent Men*
Nankin, H. R., & CALKINS, J. H. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1418 · Cited by 238 · see citing works
Buring, J. E., O'Connor, G. T., Goldhaber, S. Z., ROSNER, B. A., Herbert, P. N., Blum, C. B., Breslow, J. L., & Hennekens, C. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.22 · Cited by 224 · see citing works
High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered
Friedl, K. E., Hannan, C. J., Jones, R. E., & Plymate, S. R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90150-b · Cited by 154 · see citing works
Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man
Horst, H.-J., H�ltje, W. J., Dennis, M. J., Coert, A., Geelen, J., & Voigt, K. D. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01483589 · Cited by 128 · see citing works
Efficacy of lipid profiles in prediction of coronary disease
Kannel, W. B., & Wilson, P. W. F. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90288-7 · Cited by 128 · see citing works
Relationship of lipoprotein cholesterol concentrations to experimental atherosclerosis in baboons.
McGill, H. C., McMahan, C. A., Kruski, A. W., & Mott, G. E. (1981) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.1.1.3 · Cited by 106 · see citing works
Role of low-density lipoproteins in atherogenesis and development of coronary heart disease
Grundy, S. M. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.139 · Cited by 101 · see citing works
Mitchell, R. M., Hollls, S., Rothwell, C., & Robertson, W. R. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02669.x · Cited by 95 · see citing works
Serum testosterone and its relation to bone mineral density and body composition in normal males
Ongphiphadhanakul, B., Rajatanavin, R., Challurkit, L., Piaseu, N., Teerarungsikul, K., Sirisriro, R., Komindr, S., & Puavilai, G. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb00542.x · Cited by 79 · see citing works
Asscheman, H., Gooren, L. J., Megens, J. A. J., Nauta, J. J. P., Kloosterboer, H. J., & Eikelboom, F. A. (1994) · Metabolism · doi:10.1016/0026-0495(94)90170-8 · Cited by 65 · see citing works
Deslypère, J. P., & Vermeulen, A. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-2-430 · Cited by 51 · see citing works
The effect of testosterone replacement on plasma lipids and apolipoproteins
Jones, D. B., BILLET, J. S., Price, W. H., Edwards, C. R. W., Beastall, G. H., HIGGINS, B., SHEPHERD, J., Horn, D. B., Wenham, P. R., & SWEETING, V. M. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00256.x · Cited by 31 · see citing works
Changes in male salivary testosterone concentration with age
Read, G. F., Harper, M. E., Peeling, W. B., & Griffiths, K. (1981) · International Journal of Andrology · doi:10.1111/j.1365-2605.1981.tb00744.x · Cited by 23 · see citing works
Coronary risk factors in children of parents with premature coronary artery disease
Beigel, Y., George, J., Leibovici, L., Matityahu, A., Sclarovsky, S., & Blieden, L. C. (1993) · Acta Paediatrica · doi:10.1111/j.1651-2227.1993.tb12631.x · Cited by 20 · see citing works
LIPEMIC AND LIPOPROTEINEMIC EFFECTS OF NATURAL AND SYNTHETIC ANDROGENS IN HUMANS
Crist, D. M., Peake, G. T., & Stackpole, P. J. (1986) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1986.tb00933.x · Cited by 15 · see citing works
Wu, S., & Weng, X. (1992) · PubMed · Cited by 12 · see citing works
Is there an epidemiologic basis for a male climacteric syndrome? The Massachusetts Male Aging Study.
Jb, M. (1989) · PubMed · Cited by 8 · see citing works
[Climacteric period in men and its therapy (author's transl)].
Schlegel, W. S. (1974) · PubMed · Cited by 3 · see citing works
Schönfelder, H., & Schirren, C. (1973) · PubMed · Cited by 1 · see citing works
Changes in Male Salivary Testosterone Concentration With Age
Read, G. F., Harper, M. E., Peeling, W. B., & Griffiths, K. (1982) · The Journal of Urology · doi:10.1016/s0022-5347(17)52844-x · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Kupperman HS. Treating menopausal women and climacteric men. Medical World News 1974; 15: 32-41.
- Schlegel WS. Climacteric period in men and its therapy. Med Clin 1974; 69: 1037-9.
- Painter PC, Cope JY, Smith JL. Reference Intervals. In: Burtis CA, Ashwood ER, editors. Tietze Textbook of Clinical Chemistry. Philadelphia: Saunders, 1994: 2175-218.
- Matsumoto AM. The testis. In: Wyngaarden JB, Smith LH, editors. Cecil Textbook of Medicine, 18th Jpn Heart J January 1997 ed. Philadelphia, Saunders, 1988: 1404-21.
- American Heart Association. The cholesterol facts; a summary of the evidence relating dietary fats, serum cholesterol and coronary heart disease. Circulation 1990; 81: 1721-33.
- Mayes PA. Lipid transport and storage. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, editors. Harper's Biochemistry. New Jersey: Prentice Hall, 1993: 250-64.
- Byerley Lo, Lee WN, Swerdloff RS. Effect of modulating serum testosterone levels in the normal male range on protein, glucose, and lipid metabolism in men: implications for testosterone replacement therapy. Endoer J 1993; 1: 253-62
- Horst HJ, Holtje WJ, Dennis H. Lymphatic absorption and metabolism of orally administrated testos- terone undecanoate. Klin Wochenschr 1976; 54: 875-9.
Cited by
Sorted by citations
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079 · see citing works
Isidori, A. M., Giannetta, E., Greco, E. A., Gianfrilli, D., Bonifacio, V., Isidori, A., Lenzi, A., & Fabbri, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02339.x · Cited by 695 · see citing works
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592 · see citing works
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 586 · see citing works
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487 · see citing works
Andropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490 · see citing works
Acute Anti-Ischemic Effect of Testosterone in Men With Coronary Artery Disease
Rosano, G. M. C., Leonardo, F., Pagnotta, P., Pelliccia, F., Panina, G., Cerquetani, E., della Monica, P. L., Bonfigli, B., Volpe, M., & Chierchia, S. L. (1999) · Circulation · doi:10.1161/01.cir.99.13.1666 · Cited by 367 · see citing works
Wittert, G., Chapman, I. M., Haren, M. T., Mackintosh, S. F., Coates, P. S., & Morley, J. E. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.7.m618 · Cited by 344 · see citing works
The roles of gender, the menopause and hormone replacement on cardiovascular function
Hayward, C. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00005-5 · Cited by 314 · see citing works
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292 · see citing works
Testosterone supplementation therapy for older men: potential benefits and risks
Gruenewald, D. A., & Matsumoto, A. M. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51018.x · Cited by 279 · see citing works
Morales, A., & Lunenfeld, B. (2002) · The Aging Male · doi:10.1080/tam.5.2.74.86 · Cited by 266 · see citing works
Natural Androgens Inhibit Male Atherosclerosis
Alexandersen, P., Haarbo, J., Byrjalsen, I., Lawaetz, H., & Christiansen, C. (1999) · Circulation Research · doi:10.1161/01.res.84.7.813 · Cited by 251 · see citing works
Malkin, C. J., Pugh, P. J., Morris, P. D., Kerry, K. E., Jones, R. D., Jones, T. H., & Channer, K. S. (2004) · Heart · doi:10.1136/hrt.2003.021121 · Cited by 250 · see citing works
ANDROPAUSE: A MISNOMER FOR A TRUE CLINICAL ENTITY
Morales, Á., Heaton, J. P. W., & Carson, C. C. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67788-9 · Cited by 240 · see citing works
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Traish, A. M., Saad, F., Feeley, R. J., & Guay, A. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007245 · Cited by 237 · see citing works
Corona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0262 · Cited by 217 · see citing works
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 152 · see citing works
Testosterone and Atherosclerosis in Aging Men
Jones, R. D., Nettleship, J. E., Kapoor, D., Jones, H. T., & Channer, K. S. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505030-00001 · Cited by 111 · see citing works
Treatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97 · see citing works
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Jones, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 91 · see citing works
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 94 · see citing works
Haring, R., Baumeister, S. E., Völzke, H., Dörr, M., Felix, S. B., Kroemer, H. K., Nauck, M. A., & Wallaschofski, H. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32833c1a8d · Cited by 89 · see citing works
Swerdloff, R. S., & Wang, C. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.03.011 · Cited by 88 · see citing works
Testosterone and cardiovascular disease in men
Morris, P., & Channer, K. S. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.21 · Cited by 86 · see citing works
Androgen deficiency and atherosclerosis: The lipid link
Traish, A. M., Abdou, R. Y., & Kypreos, K. E. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.003 · Cited by 84 · see citing works
Testosterone and Coronary Artery Disease
Nettleship, J. E., Jones, R. D., Channer, K. S., & Jones, T. H. (2008) · Frontiers of hormone research · doi:10.1159/000176047 · Cited by 86 · see citing works
Androgen deficiency in aging men: Role of testosterone replacement therapy
Morley, J. E., & Perry, H. M. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.106455 · Cited by 82 · see citing works
Cornoldi, A., Caminiti, G., Marazzi, G., Vitale, C., Patrizi, R., Volterrani, M., Miceli, M., Fini, M., Spera, G., & Rosano, G. M. C. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.107 · Cited by 81 · see citing works
Juul, A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.5.423 · Cited by 80 · see citing works
Testosterone and cardiovascular disease: An old idea with modern clinical implications
Traish, A. M., & Kypreos, K. E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.078 · Cited by 73 · see citing works
Testosterone and Andropause: The Feasibility of Testosterone Replacement Therapy in Elderly Men
Lund, B. C., Bever‐Stille, K. A., & Perry, P. J. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.11.951.31574 · Cited by 71 · see citing works
Arı, Z., Kutlu, N., Uyanık, B. S., Taneli, F., Büyükyazı, G., & Tavlı, T. (2004) · International Journal of Neuroscience · doi:10.1080/00207450490430499 · Cited by 67 · see citing works
Pongkan, W., Chattipakorn, S. C., & Chattipakorn, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122503 · Cited by 64 · see citing works
HOROMONAL ERECTILE DYSFUNCTION
Morales, Á., & Heaton, J. P. W. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70138-5 · Cited by 63 · see citing works
Testosterone therapy in the aging male
Lunenfeld, B., & Nieschlag, E. (2007) · The Aging Male · doi:10.1080/13685530701485998 · Cited by 57 · see citing works
A new oral testosterone undecanoate formulation
K�hn, F.-M., & Schill, W. (2003) · World Journal of Urology · doi:10.1007/s00345-003-0372-x · Cited by 57 · see citing works
Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male
Schleich, F., & Legros, J. J. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510415 · Cited by 55 · see citing works
Testosterone Levels Among Men with Spinal Cord Injury Admitted to Inpatient Rehabilitation
Schopp, L. H., Clark, M., Mazurek, M. O., Hagglund, K. J., Acuff, M. E., Sherman, A., & Childers, M. K. (2006) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000228617.94079.4a · Cited by 53 · see citing works
Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.
Cattabiani, C., Basaria, S. S., Ceda, G. P., Luci, M., Vignali, A., Lauretani, F., Valenti, G., Volpi, R., & Maggio, M. G. (2012) · PubMed · doi:10.3275/8061 · Cited by 52 · see citing works
Androgen Deficiency as a Predictor of Metabolic Syndrome in Aging Men
Kapoor, D., & Jones, T. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00001 · Cited by 52 · see citing works
Pechersky, A., Vi, M., Семиглазов, В. Ф., Karpischenko, A., Vv, M., & Udintsev, A. V. (2002) · International Journal of Andrology · doi:10.1046/j.1365-2605.2002.00335.x · Cited by 50 · see citing works
Androgen therapy in the aging male
Lunenfeld, B. (2003) · World Journal of Urology · doi:10.1007/s00345-003-0366-8 · Cited by 47 · see citing works
Testosterone for secondary prevention in men with ischaemic heart disease?
Malkin, C. J., Pugh, P. J., Jones, T. H., & Channer, K. S. (2003) · QJM · doi:10.1093/qjmed/hcg086 · Cited by 45 · see citing works
Androgen replacement therapy in aging men with secondary hypogonadism
Morales, Á., & Lunenfeld, B. (2001) · The Aging Male · doi:10.1080/tam.4.3.151.162 · Cited by 41 · see citing works
Partial androgen deficiency, depression and testosterone treatment in aging men
Amore, M., Scarlatti, F., Quarta, A. L., & Tagariello, P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324891 · Cited by 41 · see citing works
Testosterone Replacement Therapy in Hypogonadal Men: Assessing Benefits, Risks, and Best Practices
Miner, M. M., Canty, D. J., & Shabsigh, R. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1914 · Cited by 35 · see citing works
Ebert, T., Jockenhövel, F., Morales, Á., & Shabsigh, R. (2004) · European Urology · doi:10.1016/j.eururo.2004.09.015 · Cited by 33 · see citing works
Guay, A. T., & Traish, A. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.02.004 · Cited by 32 · see citing works
Connecting the Lines between Hypogonadism and Atherosclerosis
Fahed, A. C., Gholmieh, J. M., & Azar, S. T. (2012) · International Journal of Endocrinology · doi:10.1155/2012/793953 · Cited by 28 · see citing works
Testosterone treatment to mimic hormone physiology in androgen replacement therapy
Fabbri, A., Isidori, A. M., Giannetta, E., & Lenzi, A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1093 · Cited by 22 · see citing works
Dogan, B. A., Karakılıç, E., Tuna, M. M., Arduç, A., Berker, D. S., & Güler, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12617 · Cited by 18 · see citing works
Androgen modulates cardiac fibrosis contributing to gender differences on heart failure
Chung, C., Kao, Y., Chen, Y., & Chen, Y.-J. (2013) · The Aging Male · doi:10.3109/13685538.2012.754008 · Cited by 13 · see citing works
Oral testosterone therapy: past, present, and future
Miller, J. A., Nguyen, T. T., Loeb, C. A., Khera, M., & Yafi, F. A. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead003 · Cited by 11 · see citing works
Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men
Valenti, G. (2002) · Aging Clinical and Experimental Research · doi:10.1007/bf03327345 · Cited by 11 · see citing works
Yuen, F., Thirumalai, A., Fernando, F., Swerdloff, R. S., Liu, P. Y., Pak, Y., Hull, L., Bross, R., Blithe, D., Long, J. E., et al. (2021) · Andrology · doi:10.1111/andr.13025 · Cited by 10 · see citing works
Effects of testosterone replacement on glucose and lipid metabolism
Errazuriz, I., Dube, S., Basu, A., & Basu, R. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000061 · Cited by 6 · see citing works
Andropause, androgen therapy and prostate safety
Morales, Á. (1999) · The Aging Male · doi:10.3109/13685539909003170 · Cited by 6 · see citing works
Niccoli, G., Milardi, D., D’Amario, D., Fracassi, F., Grande, G., Panico, R. A., Roberto, M., Mirizzi, A. M., Canu, G., Marinis, L. D., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314533084 · Cited by 7 · see citing works
Testosterone and cardiovascular disease
Channer, K. S., & Jones, T. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.011 · Cited by 5 · see citing works
Morales, Á., Heaton, J. P. W., & Carson, C. C. (2000) · The Journal of Urology · doi:10.1097/00005392-200003000-00003 · Cited by 5 · see citing works
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13 · see citing works
[Action of androgens on fat distribution and metabolic balance].
Tostain, J.-B., Heim, M., & Rossi, D. (2004) · PubMed · Cited by 1 · see citing works
Hypogonadism and Androgen Replacement Therapy
Kaufman, J. M., & Seftel, A. D. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7234-3266-1.50018-8 · Cited by 1 · see citing works
Testosterone Therapy and the Heart
Yaylalı, G. F., & Tolga, Y. (2011) · InTech eBooks · doi:10.5772/16594
Testosterona y su influencia sobre enfermedades cardiovasculares.
Valverde, L. F., Hernández, A. R., & Martínez, B. I. M. (2014) · Horizonte Sanitario · doi:10.19136/hs.a2n2.61
Echeverri, D., Díaz, M., Delgadillo, A., Montes, F. R., & Lizcano, F. (2007) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(07)74212-2
Testosterone and Risk Factors in the Metabolic Syndrome: Implications for Erectile Dysfunction
Guay, A. T., & Traish, A. M. (2011)
An analysis of motor coordination in fit versus less fit young adult males
McCaig, J. M. (2006) · Digital Collections - Ithaca College Library (Ithaca College)
Philipraj, S. J., Thomas, J. A., Hegde, P. M., Dorairajan, L. N., & Shah, R. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006295.pub2
The anti-inflammatory effects of testosterone on atherosclerosis
Bateman, L. (2020) · Sheffield Hallam University · doi:10.7190/shu-thesis-00351
Philipraj, S. J., Thomas, J. A., Hegde, P. M., Dorairajan, L. N., & Shah, R. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006295
Faculty Opinions recommendation of Treatment of men for "low testosterone": A systematic review.
Minhas, S., Tharakan, T., & Miah, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726764636.793556540
- Authors
- UYANIK, B. S., ARI, Z., GÜMÜS, B., YIGITOGLU, M. R., & ARSLAN, T.
- Affiliations
- Department of Biochemistry University of Celal Bayar
- Department of Urology, University of Celal Bayar
- Manisa Celal Bayar University (TR)
- Venue
- Japanese Heart Journal
- Published
- 1997
- Volume
- 38
- Issue
- 1
- Pages
- 73-82
- ISSN
- 0021-4868 (ISSN-L)
- 1348-673X
- OpenAlex
- W2319096290
- Cited by
- 75
- References
- 34
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 4
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Japanese Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone undecanoate, testosterone replacement therapy, lipoprotein profile, serum cholesterol, LDL cholesterol, estradiol, apolipoprotein A-I, apolipoprotein B, HDL cholesterol, triglycerides, coronary heart disease risk, older men, sexual function
- MeSH terms
- Aged, Aged, 80 and over, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Testosterone, Triglycerides, Body Mass Index, Testosterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review